These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 11134797

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. [Cytoplasmic islet cell antibodies and GAD antibodies in diagnosis of diabetes].
    Bieg S, Seissler J, Scherbaum WA.
    Med Klin (Munich); 1995 Oct 15; 90(10):594-8. PubMed ID: 7500923
    [No Abstract] [Full Text] [Related]

  • 23. [Evaluation of the importance of antibodies against islet cells (ICA) and Glutamate Decarboxylase(anti-GAD) for determining prognosis of diabetes type 1 in the Polish population--5 year observation].
    Kretowski A, Szelachowska M, Kinalska I.
    Pol Arch Med Wewn; 1999 Apr 15; 101(4):323-7. PubMed ID: 10740410
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. GAD antibodies seldom disappear in slowly progressive IDDM.
    Kobayashi T, Nakanishi K, Okubo M, Murase T, Kosaka K.
    Diabetes Care; 1996 Sep 15; 19(9):1031. PubMed ID: 8875105
    [No Abstract] [Full Text] [Related]

  • 27. Anti-programmed death ligand 1 therapy-induced type 1 diabetes presenting with multiple islet-related autoantibodies.
    Honoki H, Yagi K, Kambara K, Chujo D, Shikata M, Enkaku A, Takikawa-Nishida A, Liu J, Fujisaka S, Tobe K.
    J Diabetes Investig; 2020 Jan 15; 11(1):253-254. PubMed ID: 31282610
    [No Abstract] [Full Text] [Related]

  • 28. Can all newly diagnosed subjects without type 1 diabetes-associated autoimmune markers be classified as type 1b diabetic patients?
    Carreras G, Mauricio D, Pérez A, de Leiva A.
    Diabetes Care; 2000 Nov 15; 23(11):1715-6. PubMed ID: 11092309
    [No Abstract] [Full Text] [Related]

  • 29. Pancreatic autoantibodies in Tunisian children with newly diagnosed type 1 diabetes.
    Fakhfakh R, Haddouk S, Hadj Hamida YB, Kamoun T, Ayed MB, Hachicha M, Masmoudi H.
    Pathol Biol (Paris); 2008 May 15; 56(3):130-2. PubMed ID: 18178035
    [Abstract] [Full Text] [Related]

  • 30. Recurrence of immunological markers for type 1 (insulin-dependent) diabetes mellitus in immunosuppressed patients after pancreas transplantation.
    Esmatjes E, Rodríguez-Villar C, Ricart MJ, Casamitjana R, Martorell J, Sabater L, Astudillo E, Fernández-Cruz L.
    Transplantation; 1998 Jul 15; 66(1):128-31. PubMed ID: 9679835
    [Abstract] [Full Text] [Related]

  • 31. Prediction of type 1 diabetes in Sardinian schoolchildren using islet cell autoantibodies: 10-year follow-up of the Sardinian schoolchildren type 1 diabetes prediction study.
    Velluzzi F, Secci G, Sepe V, Klersy C, Shattock M, Foxon R, Songini M, Mariotti S, Locatelli M, Bottazzo GF, Loviselli A, Sardinian Autoimmunity Study Group.
    Acta Diabetol; 2016 Feb 15; 53(1):73-9. PubMed ID: 25896008
    [Abstract] [Full Text] [Related]

  • 32. Autoantibodies to a 38-kDa glycosylated islet cell membrane-associated antigen in (pre)type 1 diabetes: association with IA-2 and islet cell autoantibodies.
    Winnock F, Christie MR, Batstra MR, Aanstoot HJ, Weets I, Decochez K, Jopart P, Nicolaij D, Gorus FK, Belgian Diabetes Registry.
    Diabetes Care; 2001 Jul 15; 24(7):1181-6. PubMed ID: 11423499
    [Abstract] [Full Text] [Related]

  • 33. Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice.
    Cooke A, Mandel TE.
    J Endocrinol Invest; 1994 Jul 15; 17(7):586-93. PubMed ID: 7829835
    [No Abstract] [Full Text] [Related]

  • 34. Tyrosine-phosphatase and glutamate-decarboxylase antibodies after simultaneous pancreas kidney transplantation: do they have an impact on pancreas graft survival?
    Rodelo-Haad C, Aguera ML, Martinez-Vaquera S, Pendon-Ruiz de Mier MV, Salmeron-Rodriguez MD, Esquivias E, Navarro MD, Rodriguez-Benot A, Aljama P.
    Transplant Proc; 2015 Jul 15; 47(1):107-11. PubMed ID: 25645784
    [Abstract] [Full Text] [Related]

  • 35. Antibodies to glutamic acid decarboxylase induced by interferon-alpha therapy for chronic viral hepatitis.
    Imagawa A, Itoh N, Hanafusa T, Waguri M, Kuwajima M, Matsuzawa Y.
    Diabetologia; 1996 Jan 15; 39(1):126. PubMed ID: 8720616
    [No Abstract] [Full Text] [Related]

  • 36. Pretransplantation GAD-autoantibody status to guide prophylactic antibody induction therapy in simultaneous pancreas and kidney transplantation.
    Ringers J, van der Torren CR, van de Linde P, van der Boog PJ, Mallat MJ, Bonifacio E, Roep BO, de Fijter JW.
    Transplantation; 2013 Oct 27; 96(8):745-52. PubMed ID: 23912172
    [Abstract] [Full Text] [Related]

  • 37. Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody-positive relatives.
    Bingley PJ, Christie MR, Bonifacio E, Bonfanti R, Shattock M, Fonte MT, Bottazzo GF, Gale EA.
    Diabetes; 1994 Nov 27; 43(11):1304-10. PubMed ID: 7926304
    [Abstract] [Full Text] [Related]

  • 38. Antibodies as predictors of type 1 diabetes.
    Wilkin TJ.
    Compr Ther; 1991 Jul 27; 17(7):3-10. PubMed ID: 1742966
    [No Abstract] [Full Text] [Related]

  • 39. Course of islet autoantibody titers during Ig-immunoadsorption in a patient with newly diagnosed type 1 diabetes.
    Seidel DK, Geiss HC, Donner MG, Ritter MM, Schwandt P, Koll RA, Standl E, Ziegler AG.
    J Autoimmun; 1998 Jun 27; 11(3):273-7. PubMed ID: 9693976
    [Abstract] [Full Text] [Related]

  • 40. Glutamic acid decarboxylase (GAD65) autoantibodies in prediction of beta-cell function and remission in recent-onset IDDM after cyclosporin treatment. The Canadian-European Randomized Control Trial Group.
    Petersen JS, Dyrberg T, Karlsen AE, Mølvig J, Michelsen B, Nerup J, Mandrup-Poulsen T.
    Diabetes; 1994 Nov 27; 43(11):1291-6. PubMed ID: 7926302
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.